Lundbeck
HLUN-B.CO
#2602
Rank
โ‚น660.84 B
Marketcap
โ‚น666.07
Share price
-0.35%
Change (1 day)
6.17%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): โ‚น69.37

According to Lundbeck's latest financial reports the company's current EPS (TTM) is โ‚น73.56. In 2025 the company made an earnings per share (EPS) of โ‚น48.99 an increase over its 2024 EPS that were of โ‚น42.79.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น69.3741.6%
2025โ‚น48.9914.5%
2024โ‚น42.7929.29%
2023โ‚น33.0923.09%
2022โ‚น26.8837.26%
2021โ‚น19.59-84.61%
2020โ‚น127.28-24.61%
2019โ‚น168.82-42.06%
2018โ‚น291.3740.7%
2017โ‚น207.09146.26%
2016โ‚น84.09-120.48%
2015-โ‚น410.523231.32%
2014-โ‚น12.32-115.78%
2013โ‚น78.08-23.36%
2012โ‚น101.88-48.01%
2011โ‚น195.98-9.68%
2010โ‚น217.0013.72%
2009โ‚น190.8124.32%
2008โ‚น153.49-6.05%
2007โ‚น163.3781.77%
2006โ‚น89.87-16.76%
2005โ‚น107.98-17.58%
2004โ‚น131.01